Probes and methods of imaging a bacterial infection
US-9402925-B2 · Aug 2, 2016 · US
Oligosaccharide conjugates for targeting bacteria and uses related thereto
US9821071B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9821071-B2 |
| Application number | US-201414190928-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 26, 2014 |
| Priority date | Jan 14, 2011 |
| Publication date | Nov 21, 2017 |
| Grant date | Nov 21, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This disclosure relates to conjugates for targeting bacteria and related uses. In certain embodiments, the disclosure relates to methods of transferring a molecule of interest into bacteria comprising mixing bacteria with a non-naturally occurring conjugate under conditions such that the conjugate is transported across the bacterial cell wall. Typically, the conjugate comprises an oligosaccharide and a molecule of interest. In certain embodiments, the molecule of interest may be a tracer or an antibiotic.
First claim
Opening claim text (preview).
What is claimed is: 1. A composition comprising a positron-emitting radionuclide conjugated to maltodextrin. 2. The composition of claim 1 , wherein the positron-emitting radionuclide is selected from carbon-11, nitrogen-13, oxygen-15, fluorine-18, rubidium-82, and strontium-82. 3. The composition of claim 1 , wherein the maltodextrin has greater than 2 glucose oligomers. 4. The composition of claim 1 , wherein the composition is
Assignees
Inventors
Classifications
Macromolecular compounds, i.e. oligomers, polymers, dendrimers · CPC title
Preparation of derivatives of starch (derivatives of amylose C08B33/00; derivatives of amylopectin C08B35/00) · CPC title
Macromolecular compounds {, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules (peptides, proteins, polyamino acids A61K51/08; antibodies A61K51/10)} · CPC title
the fluorescent group being a small organic molecule · CPC title
- A61K47/61Primary
the organic macromolecular compound being a polysaccharide or a derivative thereof · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9821071B2 cover?
- This disclosure relates to conjugates for targeting bacteria and related uses. In certain embodiments, the disclosure relates to methods of transferring a molecule of interest into bacteria comprising mixing bacteria with a non-naturally occurring conjugate under conditions such that the conjugate is transported across the bacterial cell wall. Typically, the conjugate comprises an oligosacchari…
- Who is the assignee on this patent?
- Univ Emory, Georgia Tech Res Inst, Georgia State Res Foundation, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K47/61. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).